ENTITY
Lotus Pharmaceutical

Lotus Pharmaceutical (1795 TT)

41
Analysis
Health Care • Taiwan
Lotus Pharmaceutical Co., Ltd. manufactures and distributes oral medicine, ointment and injection medicine.
more
bearish•Quantitative Analysis
•29 Oct 2023 10:00

TWSE Short Interest Weekly (Oct 27th): Nan Ya Printed, Asmedia Tech, Global Unichip, TSMC

We analyzed TWSE short interest report for the past week and highlight short interest changes in Nan Ya Printed, Asmedia Tech, Global Unichip, TSMC.

Logo
595 Views
Share
bullish•Lotus Pharmaceutical
•24 Sep 2023 16:47

Lotus Pharmaceutical (1795 TT): Continued Stellar Growth in Q2; Pipeline Expansion to Drive Growth

​Lotus saw 53% YoY revenue growth in 2Q23, driven Lenalidomide and Suboxone in the US and branded products in Taiwan. EPS exceeded expectations....

Logo
578 Views
Share
bearish•Quantitative Analysis
•16 Jul 2023 10:00

TWSE Short Interest Weekly (Jul 14th): Quanta Computer, Inventec, Lite-On Tech, Walsin Lihwa, ASE

We analyzed TWSE short interest report for the past week and highlight short interest changes in Quanta Computer, Inventec, Lite-On Tech, Walsin...

Logo
433 Views
Share
bullish•Singapore Airlines
•02 Jul 2023 07:18

ECM Weekly (2nd July 2023) - Tryt, J&T Express, Redox, Kelun, 4Paradigm, SIA, M&A Research, Walsin

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
606 Views
Share
bearish•Lotus Pharmaceutical
•30 Jun 2023 17:29

Lotus Pharmaceutical Placement - Sound Fundamentals but Doesn’t Seem Well Flagged

Lotus Pharmaceutical (1795 TT)'s majority shareholder, Alvogen Emerging Markets Holdings (AEMH), aims to raise up to US$247m through an affiliated...

Logo
564 Views
Share
x